Has Matthew Sharum, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,003 in general payments to Matthew Sharum, MD across 116 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Sharum, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Sharum, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Sharum, MD

Otolaryngology · Oklahoma City, OKNPI 1336595271

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,725 of the $5,003 with a category attached, or 74.5%. 17 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 51.6% of the total. Reporting peaked in 2022 at $1,609 and has fallen 60.6% since, to $635 in 2025. Among otolaryngology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,003in general payments, 2019–2025

Across 116 payments — averaging $43.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$3K
Sanofi$567
Regeneron Healthcare Solutions, Inc.$357
Intersect ENT, Inc.$357
Stryker$304
Medtronic$248
plus $586 from 11 others

What the payments were for

Travel & lodging$94919%
Food & beverage$3,72574%
Education$3297%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	41	$2,584
Sanofi	28	$567
Regeneron Healthcare Solutions, Inc.	12	$357
Intersect ENT, Inc.	4	$357
Stryker	3	$304
Medtronic(2 entities)	2	$248
GSK	10	$180
Sanofi-aventis U.S. LLC	2	$117
Acclarent, Inc	2	$41
Kaleo, Inc.	2	$36
Alk-abello, Inc	2	$36
Merck	2	$36
ARS Pharmaceuticals Operations, Inc.	2	$32
Aerin Medical Inc.	1	$31
Neurent Medical Limited	1	$28
Greer Laboratories, Inc.	1	$26
Hologic Sales And Service, LLC	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$1,338
NA$230
SINUVA$146
FUSION$146
PROPEL$103
StealthStation$102

How this compares

$5,003 in reported general payments places this provider in the 90th percentile of 109 otolaryngology providers in Oklahoma.

See all otolaryngology providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$100,987

Medicare patients

410

Services billed

2,883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	256	$7,305
Epinephrine	34	$7,137
Ipratropium Bromide	260	$6,174
Cevimeline Hcl	16	$1,649
Fluticasone Propionate	48	$627
Betamethasone Dipropionate	18	$523
Pilocarpine Hcl	13	$396
Montelukast Sodium	26	$195
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	24	$192
Doxycycline Hyclate	13	$128
Ondansetron Hcl	30	$90
Oxycodone Hcl	29	$87
Triamcinolone Acetonide	12	$57
Prednisone	20	$37

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Oklahoma City

Kibwei McKinneyOklahoma City$315K
Richard BakerOklahoma City$17K
Edward El RassiOklahoma City$13K
Benjamin CollinsOklahoma City$10K
Keith ClarkOklahoma City$6K
Rachad MhawejOklahoma City$6K
John HouckOklahoma City$5K
Hassan HawsawiOklahoma City$5K
Brandon PiersonOklahoma City$5K
Colby McLaurinOklahoma City$4K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →